Stay updated on LY2880070 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.

Latest updates to the LY2880070 in Advanced Cancer Clinical Trial page
- Check6 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check13 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check20 days agoChange DetectedDifference0.6%
- Check28 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025, and the revision number has been updated from v2.16.2 to v2.16.4.SummaryDifference2%
- Check35 days agoChange DetectedThe page has removed a reference to a phase 1b study involving the oral chk1 inhibitor LY2880070 and its combination with gemcitabine, which was presented at the 2020 ASCO Annual Meeting.SummaryDifference2%
- Check42 days agoChange DetectedThe web page has been updated to reflect the latest version, v2.16.2, and includes new information about a phase 1b study of an oral chk1 inhibitor in combination with gemcitabine for cancer patients.SummaryDifference1%
Stay in the know with updates to LY2880070 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.